Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roy W Beck

Showing results (61-70 of 409) with videos related to

Pageof 41
Sort By:
Diabetes Technology & Therapeutics|February 24, 2025
The Association of Time-in-Range and Time-in-Tight-Range with Retinopathy Progression in the Virtual Diabetes Control and Complications Trial Continuous Glucose Monitoring DatasetBenjamin Lobo, Lauren Kanapka, Boris P Kovatchev, et al.
Diabetes Technology & Therapeutics|January 7, 2020
HbA1c Levels in Type 1 Diabetes from Early Childhood to Older Adults: A Deeper Dive into the Influence of Technology and Socioeconomic Status on HbA1c in the T1D Exchange Clinic Registry FindingsKellee M Miller, Roy W Beck, Nicole C Foster, et al.
Diabetes Technology & Therapeutics|October 29, 2019
Nonadjunctive Use of Continuous Glucose Monitoring: The End of Fingersticks?Roy W Beck, Sue A Brown, John W Lum, et al.
Diabetes Care|March 29, 2022
Response to Comment on Aleppo et al. The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin. Diabetes Care 2021;44:2729-2737Ryan Bailey, Peter Calhoun, Roy W Beck, et al.
Diabetes Care|February 8, 2019
Glucose Management Indicator (GMI): Insights and Validation Using Guardian 3 and Navigator 2 Sensor DataLalantha Leelarathna, Roy W Beck, Richard M Bergenstal, et al.
Diabetes Technology & Therapeutics|August 13, 2025
The Virtual DCCT #3: Relationship of HbA1c and CGM Metrics with Cardiovascular OutcomesWilliam B Horton, Boris P Kovatchev, Lauren G Kanapka, et al.
Lancet (London, England)|September 20, 2019
Advances in technology for management of type 1 diabetesRoy W Beck, Richard M Bergenstal, Lori M Laffel, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|October 14, 2008
Comparison of the amblyopia treatment study HOTV and the electronic-early treatment of diabetic retinopathy study visual acuity protocols in amblyopic children aged 5 to 11 yearsEileen E Birch, Samara F Strauber, Roy W Beck, et al.
Journal of Diabetes Science and Technology|September 2, 2011
Outcome measures for outpatient hypoglycemia prevention studiesRoy W Beck, Craig Kollman, Dongyuan Xing, et al.
Diabetes Technology & Therapeutics|March 2, 2005
Function of the GlucoWatch G2 Biographer during exerciseEva Tsalikian, Roy W Beck, Andrea Kalajian, et al.
Pageof 41

Showing results (61-70 of 409) with videos related to

Sort By:
Pageof 41
Diabetes Technology & Therapeutics|February 24, 2025
The Association of Time-in-Range and Time-in-Tight-Range with Retinopathy Progression in the Virtual Diabetes Control and Complications Trial Continuous Glucose Monitoring DatasetBenjamin Lobo, Lauren Kanapka, Boris P Kovatchev, et al.
Diabetes Technology & Therapeutics|January 7, 2020
HbA1c Levels in Type 1 Diabetes from Early Childhood to Older Adults: A Deeper Dive into the Influence of Technology and Socioeconomic Status on HbA1c in the T1D Exchange Clinic Registry FindingsKellee M Miller, Roy W Beck, Nicole C Foster, et al.
Diabetes Technology & Therapeutics|October 29, 2019
Nonadjunctive Use of Continuous Glucose Monitoring: The End of Fingersticks?Roy W Beck, Sue A Brown, John W Lum, et al.
Diabetes Care|March 29, 2022
Response to Comment on Aleppo et al. The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin. Diabetes Care 2021;44:2729-2737Ryan Bailey, Peter Calhoun, Roy W Beck, et al.
Diabetes Care|February 8, 2019
Glucose Management Indicator (GMI): Insights and Validation Using Guardian 3 and Navigator 2 Sensor DataLalantha Leelarathna, Roy W Beck, Richard M Bergenstal, et al.
Diabetes Technology & Therapeutics|August 13, 2025
The Virtual DCCT #3: Relationship of HbA1c and CGM Metrics with Cardiovascular OutcomesWilliam B Horton, Boris P Kovatchev, Lauren G Kanapka, et al.
Lancet (London, England)|September 20, 2019
Advances in technology for management of type 1 diabetesRoy W Beck, Richard M Bergenstal, Lori M Laffel, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|October 14, 2008
Comparison of the amblyopia treatment study HOTV and the electronic-early treatment of diabetic retinopathy study visual acuity protocols in amblyopic children aged 5 to 11 yearsEileen E Birch, Samara F Strauber, Roy W Beck, et al.
Journal of Diabetes Science and Technology|September 2, 2011
Outcome measures for outpatient hypoglycemia prevention studiesRoy W Beck, Craig Kollman, Dongyuan Xing, et al.
Diabetes Technology & Therapeutics|March 2, 2005
Function of the GlucoWatch G2 Biographer during exerciseEva Tsalikian, Roy W Beck, Andrea Kalajian, et al.
Pageof 41